A carregar...
2-Deoxyglucose and Beta-Hydroxybutyrate: Metabolic Agents for Seizure Control
Current anti-seizure drugs (ASDs) are believed to reduce neuronal excitability through modulation of ion channels and transporters that regulate excitability at the synaptic level. While most patients with epilepsy respond to ASDs, many remain refractory to medical treatment but respond favorably to...
Na minha lista:
| Publicado no: | Front Cell Neurosci |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Frontiers Media S.A.
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6503754/ https://ncbi.nlm.nih.gov/pubmed/31114484 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fncel.2019.00172 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|